Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 18, n. 1, 2026. DOI: 10.4084/MJHID.2026.044. Disponível em: https://www.mjhid.org/mjhid/article/view/6334. Acesso em: 30 jun. 2026.